NanoViricides, Inc. President Featured in Exclusive Interview With WallSt.net
NEW YORK, March 28, 2006 /PRNewswire via COMTEX/ -- On March 27, Dr. Anil Diwan, President and Director of NanoViricides, Inc. (Pink Sheets: NNVC) updated the investment community in an all-new, exclusive interview with www.wallst.net Topics covered in the interview include an overview of the Company and the markets it serves, recent press releases, current capitalization, upcoming strategic and financial milestones.
To hear the interview in its entirety, visit www.wallst.net , and click on "Interviews/Podcasts." Interviews require free registration, and can be accessed either by locating the respective company's ticker symbol under the appropriate exchange on the left-hand column of the "Interviews/Podcasts" section of the site, or by entering the respective company's ticker symbol in the Search Archive window.
About NanoViricides -- nanoviricides.com
NanoViricides, Inc. is a development stage company that is creating special purpose nanomaterials for viral therapy. A NanoViricide(TM) is a specially designed, flexible, nanomaterial that contains an encapsulated active pharmaceutical ingredient and targets it to a specific type of virus, like a guided missile. NanoViricide drugs are designed to block and dismantle the virus particles before they can infect a cell, thereby controlling viremia. This is a completely novel approach that is proving to be superior to existing approaches.
About WallSt.net
www.wallst.net is owned and operated by WallStreet Direct, Inc., a wholly owned subsidiary of Financial Media Group, Inc. The website is a provider of financial news, media, tools and community-driven applications for investors. www.wallst.net offers visitors free membership to its in-depth executive interviews, exclusive editorial content, breaking news, and several proprietary applications. In addition to its website, WallStreet Direct organizes investor conferences, publishes a newspaper, and provides multimedia advertising solutions to small and mid-sized publicly traded companies. We are expecting to receive one hundred seventy five dollars from NanoViricides, Inc. for the dissemination of this press release. For a complete list of our advertisers, and advertising relationships, visit wallst.net
Contact:
Nick Iyer
Digital Wall Street, Inc.
1-800-4-WALL-ST
SOURCE WallStreet Direct, Inc.
CONTACT: Nick Iyer of Digital Wall Street, Inc., +1-800-4-WALL-ST
URL: prnewswire.com
wallst.net
nanoviricides.com
wallst.net
www.prnewswire.com
. |
